Table of Contents

Theranostics

• Clinical

  • You have access

    Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of ¹⁷⁷Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

    John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Sue-Ping Thang, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, David Pattison, Alexis Beaulieu, Jennifer Mooi, Ben Tran, Christina Guo, Victor Kalff, Declan G Murphy, Price Jackson, Peter Eu, Mark Scalzo, Scott Williams, Rodney J. Hicks and Michael S. Hofman

    Journal of Nuclear Medicine June 1, 2020, 61 (6) 857-865; DOI: https://doi.org/10.2967/jnumed.119.236414
  • You have access

    3-Year Freedom from Progression After ⁶⁸Ga-PSMA PET/CT–Triaged Management in Men with Biochemical Recurrence After Radical Prostatectomy: Results of a Prospective Multicenter Trial

    Louise Emmett, Reuben Tang, Rohan Nandurkar, George Hruby, Paul Roach, Jo Anne Watts, Thomas Cusick, Andrew Kneebone, Bao Ho, Lyn Chan, Pim J. van Leeuwen, Matthijs J. Scheltema, Andrew Nguyen, Charlotte Yin, Andrew Scott, Colin Tang, Michael McCarthy, Karen Fullard, Matthew Roberts, Roslyn Francis and Phillip Stricker

    Journal of Nuclear Medicine June 1, 2020, 61 (6) 866-872; DOI: https://doi.org/10.2967/jnumed.119.235028
  • You have access

    Diagnostic Value of ⁶⁸Ga-PSMA PET/CT for Detection of Phosphatase and Tensin Homolog Expression in Prostate Cancer: A Pilot Study

    BaoJun Wang, Jie Gao, Qing Zhang, Yao Fu, Guangxiang Liu, Jiong Shi, Danyan Li, Feng Wang and Hongqian Guo

    Journal of Nuclear Medicine June 1, 2020, 61 (6) 873-880; DOI: https://doi.org/10.2967/jnumed.119.236059
  • You have access

    ¹⁸F-DCFPyL PET/CT Imaging in Patients with Biochemically Recurrent Prostate Cancer After Primary Local Therapy

    Esther Mena, Maria Liza Lindenberg, Ismail Baris Turkbey, Joanna H. Shih, Stephanie A. Harmon, Ilhan Lim, Frank Lin, Stephen Adler, Philip Eclarinal, Yolanda L. McKinney, Deborah Citrin, William Dahut, Bradford J. Wood, Venkatesh Krishnasamy, Richard Chang, Elliot Levy, Maria Merino, Peter Pinto, Janet F. Eary and Peter L. Choyke

    Journal of Nuclear Medicine June 1, 2020, 61 (6) 881-889; DOI: https://doi.org/10.2967/jnumed.119.234799
  • You have access

    ⁶⁴Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor–Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial

    Ebrahim S. Delpassand, David Ranganathan, Nilesh Wagh, Afshin Shafie, Ayman Gaber, Ali Abbasi, Andreas Kjaer, Izabela Tworowska and Rodolfo Núñez

    Journal of Nuclear Medicine June 1, 2020, 61 (6) 890-896; DOI: https://doi.org/10.2967/jnumed.119.236091

  • FEATURED ARTICLE OF THE MONTH

    • You have access

      Head-to-Head Comparison of ⁶⁸Ga-DOTA-JR11 and ⁶⁸Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: A Prospective Study

      Wenjia Zhu, Yuejuan Cheng, Xuezhu Wang, Shaobo Yao, Chunmei Bai, Hong Zhao, Ru Jia, Jianming Xu and Li Huo

      Journal of Nuclear Medicine June 1, 2020, 61 (6) 897-903; DOI: https://doi.org/10.2967/jnumed.119.235093

• Basic

  • FEATURED BASIC SCIENCE ARTICLE

    • You have access

      Differential Expression of Glucose Transporters and Hexokinases in Prostate Cancer with a Neuroendocrine Gene Signature: A Mechanistic Perspective for ¹⁸F-FDG Imaging of PSMA-Suppressed Tumors

      Martin K. Bakht, Jessica M. Lovnicki, Janice Tubman, Keith F. Stringer, Jonathan Chiaramonte, Michael R. Reynolds, Iulian Derecichei, Rosa-Maria Ferraiuolo, Bre-Anne Fifield, Dorota Lubanska, So Won Oh, Gi Jeong Cheon, Cheol Kwak, Chang Wook Jeong, Keon Wook Kang, John F. Trant, Colm Morrissey, Ilsa M. Coleman, Yuzhuo Wang, Hojjat Ahmadzadehfar, Xuesen Dong and Lisa A. Porter

      Journal of Nuclear Medicine June 1, 2020, 61 (6) 904-910; DOI: https://doi.org/10.2967/jnumed.119.231068